End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.78 CAD | +9.86% | +50.00% | +173.68% |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Novel Oral Thin Film
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | +9.37% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Europe
80.8
%
| 1 | 73.8 % | 1 | 80.8 % | +19.83% |
United States
18.6
%
| 0 | 15.3 % | 0 | 18.6 % | +33.10% |
Canada
0.6
%
| 0 | 10.9 % | 0 | 0.6 % | -94.23% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dwight Gorham
CEO | Chief Executive Officer | 66 | 12/04/23 |
André Godin
DFI | Director of Finance/CFO | 61 | 19/07/15 |
Horst Zerbe
CHM | Chairman | 77 | 31/03/06 |
Nadine Paiement
CTO | Chief Tech/Sci/R&D Officer | 47 | 31/05/05 |
Investor Relations Contact | - | - | |
Tommy Kenny
LAW | General Counsel | 37 | 31/12/15 |
David Kideckel
PRN | Corporate Officer/Principal | - | 19/03/23 |
Ingrid Zerbe
SEC | Corporate Secretary | 69 | 31/03/06 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Horst Zerbe
CHM | Chairman | 77 | 31/03/06 |
Mark Nawacki
BRD | Director/Board Member | 54 | 08/08/16 |
Bernd Melchers
BRD | Director/Board Member | 72 | 07/04/09 |
Monika Trzcinska
BRD | Director/Board Member | 57 | 09/05/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 174,658,096 | 135,542,895 ( 77.60 %) | 0 | 77.60 % |
Company contact information
IntelGenx Technologies Corp.
6420 Abrams
H4S 1Y2, Ville Saint-Laurent
+514 331 7440
http://www.intelgenx.comSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+20.76% | 43.77B | |
+28.00% | 22.83B | |
+20.25% | 15.56B | |
+18.82% | 14.34B | |
+55.83% | 12.96B | |
-0.05% | 6.79B | |
-12.70% | 6.41B | |
-8.87% | 5.73B | |
+14.65% | 5.69B |
- Stock Market
- Equities
- IGXT Stock
- IGX Stock
- Company IntelGenx Technologies Corp.